Sysmex España

What Sysmex España does

Sysmex España S.L. is the Iberian (Spain and Portugal) operating subsidiary of Sysmex Europe SE (Hamburg), itself a subsidiary of Tokyo-listed Sysmex Corporation (6869.T). Founded in 2010 and headquartered in Sant Just Desvern (Barcelona), the company employs approximately 200 people and sells, services, and supports in vitro diagnostic (IVD) systems for hospital laboratories, independent clinical laboratories, oncology centers, and veterinary facilities. Its product portfolio spans hematology (XR-Series, XN-Series), hemostasis (CN-Series, CS-1600), urinalysis (UN-Series, UF-4000/5000), clinical and industrial flow cytometry, oncology molecular diagnostics (OSNA, OncoBEAM, MammaTyper, Sentimag/Magseed), and rapid antimicrobial susceptibility testing (PA-100 AST). Underlying technologies include fluorescence flow cytometry, digital PCR with unique molecular identifiers (SafeSEQ/Plasma-SeqSensei), BEAMing liquid biopsy, microfluidic AST, and magnetic tracer-based surgical localization.

The business model is a classic razor-and-blade IVD model: instruments are sold or placed under reagent-rental arrangements, while ongoing revenue comes from proprietary Sysmex-branded reagents, controls, and calibrators that are required for warranty and optimal performance. Recurring revenue is augmented by service and maintenance contracts, the Caresphere Digital Solutions / Caresphere Academy software and training platform, IQAS Online external quality assessment, and Lean Six Sigma-based laboratory optimization consulting. Distribution in Iberia is direct (specialist field sales teams per product line: hematology, hemostasis, urinalysis, oncology/life science, flow cytometry), while broader EMEA reach is delivered through a distributor network coordinated by Sysmex Europe. The entity itself is a private Sociedad Limitada; ultimate parent Sysmex Corporation is publicly listed and reports global operations across 190 countries with 9,000+ employees.

Name

Sysmex España

Legal name

Sysmex España S.L.

Website

https://sysmex.es

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Sysmex España S.L. is the Iberian (Spain and Portugal) subsidiary of Japan's Sysmex Corporation, providing in vitro diagnostic instruments, reagents, and software for clinical laboratories and hospitals across hematology, hemostasis, urinalysis, flow cytometry, and oncology diagnostics.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics (IVD) Equipment and Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Veterinary Services (54194), Veterinary Services (541940)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK), Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)

Keywords

• In-vitro diagnostics
• Hematology analyzers
• Clinical laboratory automation
• Oncology molecular diagnostics
• Reagent rental model

Headquarters

HQ city

Sant Just Desvern

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Instrument sales with recurring reagent revenue (reagent rental model): Core business model: instruments are sold or placed in laboratories, generating recurring revenue through proprietary reagents, controls, and calibrators specifically designed for the Sysmex system. Users are required to use the complete Sysmex system for optimal performance and warranty.
2. Service contracts and maintenance: Installation, repair, maintenance, and ongoing technical support for diagnostic instruments including telephone assistance. Post-sale monitoring and customer care services form part of the revenue stream.
3. Software and integrated solutions licensing: Software solutions such as Caresphere (Quality Management, Operational Support, Digital Solutions) and Extended IPU provide laboratory management and workflow optimization tools as part of the integrated product ecosystem.
4. Professional services and consulting: Laboratory workflow consulting services based on Lean Six Sigma methodologies, aimed at increasing laboratory productivity. Services include optimization studies and laboratory economics consulting.
5. Life Science and cytogenetics products (OGT): Oxford Gene Technology subsidiary provides cytogenetic and molecular genetic products including CytoCell FISH probes, CytoSure CGH-arrays, and SureSeq NGS panels for clinical and research use.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels9 records

Core offering

Sysmex España sells and services integrated in-vitro diagnostic (IVD) systems for clinical laboratories across hematology, hemostasis/coagulation, urinalysis, oncology (including molecular diagnostics and liquid biopsy), flow cytometry, point-of-care rapid antimicrobial susceptibility testing, and veterinary hematology. The commercial model combines placement/sale of proprietary analyzers with recurring revenue from Sysmex-branded reagents, controls, and calibrators, supported by Caresphere software, IQAS Online quality control, and laboratory consulting/training services.

Product overview

Sysmex España is a diagnostic solutions company offering integrated products across multiple healthcare domains: hematology (XR-Series, XN-Series analyzers), hemostasis/coagulation (CN Series, CA analyzers), urinalysis (UN-Series, UF analyzers), oncology (OSNA molecular diagnostics, MammaTyper, OncoBEAM liquid biopsy, Sentimag), flow cytometry (clinical and industrial), and point-of-care testing (PA-100 AST System). The portfolio includes acquired brands from Oxford Gene Technology (CytoCell, CytoSure, SureSeq), and is supported by services including Caresphere Academy training platform, Caresphere Digital Solutions for laboratory integration, and consulting services. Products operate within the Sysmex system using proprietary reagents, controls, and calibrators for optimized performance.

Differentiator

Problem solved

Functional benefit

Brands

• Sysmex Academy: Educational platform for healthcare professionals offering training, courses, webinars, and scientific resources
• Caresphere
• OSNA
• Xtra
• SEED

Products and services

• XR-Series Hematology Analyzers
• XN-Series Hematology Analyzers
• XN-L Series Hematology Analyzers
• XN-V Series Veterinary Hematology Analyzers
• CN Series Hemostasis Analyzers
• CS-1600 Hemostasis Analyzer
• CA-620 / CA-660 Coagulation Analyzers
• UN-Series Urinalysis Analyzers
• UF-1500 Urine Particle Analyzer
• UF-4000 / UF-5000 Urine Particle Analyzers
• UC-3500 Automated Urine Strip Analyzer
• OSNA Molecular Diagnostic Assay
• MammaTyper Breast Cancer Diagnostic Test
• OncoBEAM RAS CRC Kit
• Plasma-SeqSensei Liquid Biopsy Kits
• Sentimag System with Magseed and Magtrace
• CALiaGold Calprotectin Immunoassay
• CytoCell FISH Probes
• CytoSure CGH-Array
• SureSeq NGS Panels
• PA-100 AST System
• Sysmex FIT DX Series
• XF-1600 Clinical Flow Cytometer
• SARS-CoV-2 / COVID-19 Diagnostic Tests
• Caresphere Academy
• Caresphere Digital Solutions
• IQAS Online Quality Control
• Sysmex Laboratory Consulting Services
• PS-10 Sample Preparation System
• Caresphere QM Operational Support

Quantifiable outcome

• OncoBEAM technology is nearly 20x more sensitive than conventional PCR and standard NGS methods for ctDNA detection
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Ten partnerships are on record, tiered core, secondary and minor.

• CellaVision ABcoreStrategic or Co-development Partner · 6 February 2024Strategic alliance agreement to advance hematology solutions by expanding the portfolio, including next-generation cell morphology analyzers. Companies will work to increase efficiency and standardization of testing workflows, increase precision of cell morphology classification, and provide value in supporting diagnosis. Sysmex Corporation and CellaVision AB.
• Cerca BiotechsecondaryChannel Partner/ Reseller/ Distributor · 24 April 2023European distribution agreement for MammaTyper, an advanced breast cancer diagnostic assay. Sysmex Europe distributes MammaTyper as part of the Sysmex Life Science portfolio in EMEA.
• Sentinel DiagnosticssecondaryChannel Partner/ Reseller/ Distributor · 13 March 2023Distribution partnership for the SENTiFIT 800 Analyser, a fully automated and high-throughput system for fecal immunochemical test (FIT). Sentinel Diagnostics develops and produces in vitro diagnostics; Sysmex distributes throughout EMEA as part of the FIT offering.
• Siemens HealthineerscoreOEM/ Whitelabel/ Licensing Partner · 8 March 2023Global OEM agreement on hemostasis products where each company supplies the other with their products in the diagnostic field of hemostasis on an OEM basis. Sysmex Corporation and Siemens Healthcare Diagnostics Inc. signed the agreement effective February 28, 2023.
• JCR PharmaceuticalsminorStrategic or Co-development Partner · 3 October 2022Joint venture in regenerative medicine and cell therapy field, aiming for research and development and early commercialization of regenerative medicine products using stem cells. Sysmex Corporation and JCR Pharmaceuticals established the joint venture.
• Astrego Diagnostics ABcoreStrategic or Co-development Partner · 29 January 2021Sysmex Corporation invested in Astrego Diagnostics AB (Uppsala, Sweden) to help commercialize a rapid drug susceptibility test for urinary tract infections (UTIs). Astrego was later renamed Sysmex Astrego AB and won the Longitude Prize on AMR in 2024.
• SphingoTec GmbHminorChannel Partner/ Reseller/ Distributor · 14 January 2020Exclusive distribution agreement for the Nexus IB10 diagnostic platform by Hitado GmbH (Sysmex point-of-care subsidiary) in Germany. Sysmex Suisse AG commercializes the platform in Switzerland.
• Endomag (Endomagnetics Ltd)secondaryTechnology or IntegrationEndomag supplies the Sentimag system and Magseed/Magtrace magnetic tracers used for sentinel lymph node localization in breast cancer surgery. Products carry CE certification. Endomag is a registered European Union trademark of Endomagnetics Ltd.
• World Cancer Research Fund (WCRF)minorOthersSysmex participates in the 'Sysmex Against Cancer' project, raising donations from partners, employees, and society for the World Cancer Research Fund to support cancer research.
• Ajinomoto Foundation / NEC CorporationminorStrategic or Co-development PartnerCross-industry co-creation project to improve maternal and child health and nutrition in the Republic of Ghana, contributing to Universal Nutrition Health Coverage. Sysmex participates alongside Ajinomoto Foundation and NEC Corporation.

Scale indicators3 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Hologic: Strong in molecular diagnostics and oncology, including women health (breast cancer). Comparable to Sysmex's OSNA, MammaTyper, and OncoBEAM oncology portfolio.
• CellaVision: Digital cell morphology specialist and Sysmex's strategic alliance partner. Directly comparable in hematology workflow, particularly in cell morphology classification adjacent to Sysmex's XN analyzers.
• Horiba Medical: Specialized hematology and clinical chemistry manufacturer. Directly comparable as a focused hematology IVD peer with similar instrument-reagent model serving hospitals and clinical labs.

Broad incumbents

• Roche Diagnostics: Largest global IVD player and a direct competitor in hematology, coagulation, urinalysis, and oncology diagnostics. Comparable due to overlapping instrument-reagent business model and similar hospital lab customer base across EMEA.
• Siemens Healthineers: Direct competitor in hemostasis and broader IVD, and a strategic OEM partner for Sysmex. Highly comparable given mutual product cross-supply and shared hospital lab customer base.
• Bio-Rad Laboratories: Clinical diagnostics and life science tools company with overlapping quality control and hematology offerings. Comparable in the lab QC and IVD consumables space.
• Becton Dickinson (BD Biosciences): Major flow cytometry and clinical lab IVD player. Comparable to Sysmex's clinical flow cytometry (XF-1600, PS-10) and broader lab workflow offerings.
• Abbott Diagnostics: Major IVD competitor across hematology, immunoassay, and molecular diagnostics with a global recurring reagent model. Overlaps with Sysmex in clinical labs and hospital channels in Iberia and broader EMEA.
• Danaher (Beckman Coulter): Major hematology and clinical chemistry competitor with a strong reagent-analyzer ecosystem. Directly comparable in routine laboratory diagnostics served by Sysmex España.

Emerging players

• Mindray: Chinese IVD player expanding aggressively in EMEA hematology and urinalysis with cost-competitive instruments. Comparable as a recurring reagent business targeting the same clinical lab segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Sysmex_Es
• LinkedInlinkedin.com/company/sysmex-espana

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sysmex España